[Platelet activating factor (PAF) and its inhibitors].
Rydzewska
G
G
Gabryelewicz
A
A
D000707:Anaphylaxis / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D004066:Digestive System Diseases / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006636:Histamine Release / Q000187:drug effects; D006801:Humans; D017705:Lignans; D008031:Lignin / Q000627:therapeutic use; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors / Q000502:physiology*; D013729:Terpenes / Q000627:therapeutic use
D006634:Histamine H1 Antagonists; D017705:Lignans; D010972:Platelet Activating Factor; D013729:Terpenes; D008031:Lignin
Czynnik aktywujacy płytki (PAF) i jego inhibitory.